Magnetic resonance-guided laser interstitial thermal therapy vs. open surgery for drug-resistant mesial temporal lobe epilepsy: a propensity score matched retrospective cohort study.

Autor:	Mo J; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Guo Z; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Wang X; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Zhang J; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Hu W; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Shao X; Neurology, Beijing Tiantan Hospital.; China National Clinical Research Center for Neurological Disease, NCRC-ND., Sang L; Department of Neurosurgery, Beijing Fengtai Hospital, Beijing, China., Zheng Z; Department of Neurosurgery, Beijing Fengtai Hospital, Beijing, China., Zhang C; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University., Zhang K; Departments of Neurosurgery.; Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University.
Jazyk:	angličtina
Zdroj:	International journal of surgery (London, England) [Int J Surg] 2024 Jan 01; Vol. 110 (1), pp. 306-314. Date of Electronic Publication: 2024 Jan 01.
DOI:	10.1097/JS9.0000000000000811
Abstrakt:	Background: Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) and traditional open surgery (OS) are effective and safe options for patients with drug-resistant mesial temporal lobe epilepsy (DR-mTLE). However, their superiority in seizure control and preservation of functional abilities remains unclear. This study aimed to compare the surgical outcomes of MRgLITT and OS. Materials and Methods: This multicenter retrospective cohort study included patients with DR-mTLE who underwent MRgLITT or OS at three centres between 2015 and 2023. The data on patient demographics, presurgical non-invasive evaluation, stereoelectroencephalography (SEEG) implantation, memory alteration, and seizure outcomes were collected. Propensity score matching (PSM) analysis was conducted for the comparison of seizure control and functional preservation between two surgical approaches. Results: Of the 244 individuals who met the study criteria, 33 underwent MRgLITT and 211 OS. The median (interquartile range) age at seizure onset was 22.0 (13.0) and 12.3 (10.0) years in the MRgLITT and OS groups, respectively. The first PSM, based on demographic and non-invasive information, resulted in 26 matched pairs for the primary analysis. There were no significant differences in memory preservation ( P = 0.95) or surgical outcomes ( P = 0.96) between the groups. The second PSM, based on demographics and SEEG implantation, yielded 32 matched pairs for the sensitivity analysis, showing similar results. Subset analysis of early and late MRgLITT cases revealed no statistically significant differences in the proportion of patients with memory decline ( P = 0.42) or seizure control ( P = 1.00). Patients who underwent SEEG implantation were 96% less likely to achieve seizure freedom after MRgLITT ( P = 0.02). Conclusion: Minimally invasive MRgLITT is associated with memory preservation and seizure control, similar to traditional OS. MRgLITT is effective and safe for DR-mTLE and is relevant for future prospective randomized trials on dominant-side mTLE, providing practical implications for guiding neurosurgeons in the selection of surgical approaches. (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu